Key result
Gradient boosting model predicts frailty risk in adults with chronic disease with ~0.82 AUC.
Why the study?
Individuals with chronic diseases are at higher risk of developing frailty, but predictive models for frailty risk in this population and their generalizability across populations are lacking.
Can a machine learning model accurately predict frailty risk in middle-aged and older adults with chronic diseases?
Observational (n=8,535)
Yes
Can a machine learning model accurately predict frailty risk in middle-aged and older adults with chronic diseases?
Effect estimate: AUC 0.815 (95% CI 0.797-0.833)
A Gradient Boosting Decision Tree model using predictors like sleep duration, education, cognitive impairment, age, and visual impairment can effectively predict frailty risk in older adults with chronic diseases.
May aid frailty prediction in chronic disease patients; leaves open prospective validation before clinical adoption.
Objectives Chronic diseases and frailty are both prevalent among middle-aged and older adults. Individuals with chronic disorders are at a higher risk of developing frailty. This study aims to develop and validate a machine learning model for predicting frailty risk among middle-aged and older adults with chronic diseases, and to assess their generalizability across Chinese and American populations. Method Data from the China Health and Retirement Longitudinal Study (CHARLS) were utilized and split into a training set and an internal validation set at a ratio of 7:3. A subset from the National Health and Nutrition Examination Survey (NHANES) served as the external validation set. Seven machine learning algorithms were employed to predict frailty risk, with feature selection performed using LASSO regression. The SHapley Additive explanation (SHAP) analysis was applied to enhance model interpretability. Results Among the 8,535 CHARLS participants, frailty was identified in 23.7% of patients. The Gradient Boosting Decision Tree (GBDT) model demonstrated the best decision-making performance compared to other models, with an AUC of 0.815 (95% CI: 0.797, 0.833) in the internal validation set, accuracy of 0.735 (95% CI: 0.681, 0.752), sensitivity of 0.751 (95% CI: 0.722, 0.844), and specificity of 0.730 (95% CI: 0.633, 0.6752). In the external validation set, the GBDT model achieved an AUC of 0.748 (95% CI: 0.721, 0.775). SHAP revealed the five most important predictors influencing frailty risk: sleep duration, education level, cognitive impairment, age, and visual impairment. Conclusion The GBDT model developed effectively predicts the risk of frailty in middle-aged and older adult patients and may serve as a practical tool for the early identification of high-risk populations. In the future, the generalizability of this model requires validation across more diverse cultural contexts to enhance its broader applicability.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2026) conducted an observational in Frailty in chronic diseases (n=8,535). Gradient Boosting Decision Tree (GBDT) model vs. Other machine learning models was evaluated on Frailty risk prediction (AUC in internal validation) (AUC 0.815, 95% CI 0.797-0.833). The Gradient Boosting Decision Tree model predicted frailty risk in middle-aged and older adults with chronic diseases with an AUC of 0.815 (95% CI 0.797-0.833) in internal validation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: